Arthur Taveras X4 Pharmaceuticals, Inc (XFOR) insider trading activity
Arthur Taveras is Chief Scientific Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 388,026 shares of XFOR, which is worth approximately $201,773. The most recent transaction as insider was on Oct 07, 2024, when has been sold 76,920 shares (Common Stock) at a price of $0.56 per share, resulting in proceeds of $43,075. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
388K
65.61%
3M change
55.63%
12M change
Total Value Held
$201,773
Arthur Taveras Transaction History
AT
Arthur Taveras
Chief Scientific Officer
Boston, MA